Intervention not reported
Face‐to‐face behavioral intervention vs minimal or no support (Measured 3 to 6 months with CO‐validated prolonged and continuous abstinence, and self‐reported abstinence) · people who use waterpipe
The intervention may leads to higher face‐to‐face behavioral intervention vs minimal or no support… (low certainty).
1 finding from 1 review
RR 2.64 [1.66, 4.2]
851 participants
Low
Smoking abstinence at longest · people who smoke
Varenicline leads to higher smoking abstinence at longest compared with placebo or no medication (high certainty).
1 finding from 1 review
Smoking abstinence at longest · people who smoke
Cytisine may leads to higher smoking abstinence at longest compared with nicotine replacement therapy (low certainty).
1 finding from 1 review
Smoking abstinence at longest · people who smoke
Varenicline leads to higher smoking abstinence at longest compared with bupropion (high certainty).
1 finding from 1 review
Smoking abstinence at longest · people who smoke
Varenicline leads to higher smoking abstinence at longest compared with nicotine replacement therapy monotherapy (high certainty).
1 finding from 1 review
Smoking abstinence at longest · people who smoke
Varenicline showed no clear difference in smoking abstinence at longest compared with combination nicotine replacement therapy (low certainty).
1 finding from 1 review
Smoking abstinence at longest · people who continued to smoke tobacco following acute coronary syndrome
It is very uncertain whether varenicline changes smoking abstinence at longest compared with e‐cigarettes (very low certainty).
1 finding from 1 review
Smoking abstinence at longest · people who smoke
Cytisine probably leads to higher smoking abstinence at longest compared with placebo or no medication (moderate certainty).
1 finding from 1 review
Smoking abstinence at longest · people who smoke
Cytisine showed no clear difference in smoking abstinence at longest compared with varenicline (low certainty).
1 finding from 1 review
Systolic blood pressure · patients with diabetes with or without CKD
1 finding from 1 review
Diastolic blood pressure · patients with diabetes with or without CKD
1 finding from 1 review
Extent of substance use at long‐term · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
Extent of substance use at long‐term · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
Extent of substance use at long‐term · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
Extent of substance use at long‐term · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
Function in the long term Measured using AOFAS score (0 to 100, higher scores indicate improved function) · people aged over 14 years with displaced intra‐articular calcaneal fractures
1 finding from 1 review
CTS symptoms (Boston CTS questionnaire) ‐ long‐term improvement: > 3 monthsScale: 1 to 5, higher is worse · carpal tunnel syndrome
1 finding from 1 review
Function (Boston CTS questionnaire) ‐ Long‐term improvement: > 3 monthsScale: 1 to 5, higher is worse · carpal tunnel syndrome
1 finding from 1 review
Health‐related quality of life ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
1 finding from 1 review
Medium‐ to long‐term complications( · people undergoing elective bifurcated abdominal endovascular aneurysm repair
Totally percutaneous showed no clear difference in medium‐ to long‐term complications( compared with cut‐down femoral artery access (moderate certainty).
1 finding from 1 review